Profile
Sector:
HealthcareIndustry:
BiotechnologyCountry:
United StatesIPO:
Website:
http://tnfpharma.comNext earnings report:
14 November 2024Last dividends:
N/ANext dividends:
N/APrice
regular market | Wed, 30 Oct 2024 13:30:00 GMTDividend
Analysts recommendations
Institutional Ownership
Included in screeners
What type of business is TNF Pharmaceuticals?
TNF Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on developing two novel therapeutic platforms that treat the causes of disease rather than addressing the symptoms. Its MYMD-1 is a drug platform based on a clinical stage small molecule that regulates the immune system to control TNF-a, which drives chronic inflammation, and other pro-inflammatory cell signaling cytokines. The MYMD-1 is being developed to treat diseases and disorders marked by acute or chronic inflammation. The company's second drug platform, Supera-CBD, is being developed to treat chronic pain, addiction, and epilepsy. The Supera-CBD is a novel synthetic derivative of cannabidiol (CBD) and is being developed to address and improve the growing CBD market, which includes FDA approved drugs and CBD products not regulated as drugs. TNF Pharmaceuticals, Inc. was formerly known as MyMD Pharmaceuticals, Inc. and changed its name to TNF Pharmaceuticals, Inc. in July 2024. The company was founded in 2014 and is headquartered in Baltimore, Maryland.
What sector is TNF Pharmaceuticals in?
TNF Pharmaceuticals is in the Healthcare sector
What industry is TNF Pharmaceuticals in?
TNF Pharmaceuticals is in the Biotechnology industry
What country is TNF Pharmaceuticals from?
TNF Pharmaceuticals is headquartered in United States
What is TNF Pharmaceuticals website?
https://tnfpharma.com
Is TNF Pharmaceuticals in the S&P 500?
No, TNF Pharmaceuticals is not included in the S&P 500 index
Is TNF Pharmaceuticals in the NASDAQ 100?
No, TNF Pharmaceuticals is not included in the NASDAQ 100 index
Is TNF Pharmaceuticals in the Dow Jones?
No, TNF Pharmaceuticals is not included in the Dow Jones index
When was TNF Pharmaceuticals the previous earnings report?
No data
When does TNF Pharmaceuticals earnings report?
The next expected earnings date for TNF Pharmaceuticals is 14 November 2024